Molecular profiling of colon tumors: The search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predisposition

Annals of Surgical Oncology

Volumn 18, Issue 13, 2011, Pages 3694-3700

  Bacolod, Manny D ^a,b   Barany, Francis ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PANITUMUMAB;

CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER SURGERY; CANCER SUSCEPTIBILITY; CHROMOSOMAL INSTABILITY; CHROMOSOME 18Q; CHROMOSOME LOSS; COLONOSCOPY; COLORECTAL CANCER; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; HOMOZYGOSITY; HUMAN; PROGNOSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

COLONIC NEOPLASMS; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 82955189738     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1615-5     Document Type: Review

References (62)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin. 55 74 108 15761078 10.3322/canjclin.55.2.74 (Pubitemid 40372904)
2. FE Ahmed 2003 Colon cancer: prevalence, screening, gene expression and mutation, and risk factors and assessment J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 21 65 131 15845222 (Pubitemid 37466162)
3. HT Lynch JF Lynch PM Lynch T Attard 2008 Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management Fam Cancer. 7 27 39 17999161 10.1007/s10689-007-9165-5 1:CAS:528: DC%2BD1cXitlahs78%3D
4. C Lengauer KW Kinzler B Vogelstein 1997 Genetic instability in colorectal cancers Nature. 386 623 627 9121588 10.1038/386623a0 1:CAS:528: DyaK2sXisFCntrk%3D (Pubitemid 27175430)
5. JR Eshleman SD Markowitz 1995 Microsatellite instability in inherited and sporadic neoplasms Curr Opin Oncol. 7 83 89 7696368 1:CAS:528: DyaK2sXkt1anu7Y%3D
6. YW Cheng H Pincas MD Bacolod G Schemmann SF Giardina J Huang, et al. 2008 CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer Clin Cancer Res. 14 6005 6013 18829479 10.1158/1078-0432.CCR-08-0216 1:CAS:528:DC%2BD1cXhtF2nurrN
7. ER Fearon B Vogelstein 1990 A genetic model for colorectal tumorigenesis Cell. 61 759 767 2188735 10.1016/0092-8674(90)90186-I 1:CAS:528: DyaK3cXktlyhtrg%3D (Pubitemid 20185636)
8. J Behrens 2005 The role of the Wnt signalling pathway in colorectal tumorigenesis Biochem Soc Trans. 33 672 675 16042571 10.1042/BST0330672 1:CAS:528:DC%2BD2MXmvFSnu7w%3D (Pubitemid 41160836)
9. NS Fearnhead MP Britton WF Bodmer 2001 The ABC of APC Hum Mol Genet. 10 721 733 11257105 10.1093/hmg/10.7.721 1:CAS:528:DC%2BD3MXjt1ajsb0%3D (Pubitemid 32331581)
10. T Sjoblom S Jones LD Wood DW Parsons J Lin TD Barber, et al. 2006 The consensus coding sequences of human breast and colorectal cancers Science. 314 268 274 16959974 10.1126/science.1133427 (Pubitemid 44571966)
11. LD Wood DW Parsons S Jones J Lin T Sjoblom RJ Leary, et al. 2007 The genomic landscapes of human breast and colorectal cancers Science. 318 1108 1113 17932254 10.1126/science.1145720 1:CAS:528:DC%2BD2sXht1ykurrP (Pubitemid 350134889)
12. MF Kane M Loda GM Gaida J Lipman R Mishra H Goldman, et al. 1997 Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines Cancer Res. 57 808 811 9041175 1:CAS:528:DyaK2sXhs1Kjtbs%3D (Pubitemid 27097998)
13. B Jung EJ Smith RT Doctolero P Gervaz JC Alonso K Miyai, et al. 2006 Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers Int J Cancer. 118 2509 2513 16380996 10.1002/ijc.21710 1:CAS:528:DC%2BD28XktlGiu70%3D
14. A McGivern CV Wynter VL Whitehall T Kambara KJ Spring MD Walsh, et al. 2004 Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer Fam Cancer. 3 101 107 15340260 10.1023/B:FAME.0000039861.30651.c8 1:CAS:528:DC%2BD2cXntFCntbg%3D (Pubitemid 40645891)
15. M Nannini MA Pantaleo A Maleddu A Astolfi S Formica G Biasco 2009 Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives Cancer Treat Rev. 35 201 209 19081199 10.1016/j.ctrv.2008.10. 006 1:CAS:528:DC%2BD1MXksVantrw%3D
16. DS Dunican P McWilliam O Tighe A Parle-McDermott DT Croke 2002 Gene expression differences between the microsatellite instability (MIN) and chromosomal instability (CIN) phenotypes in colorectal cancer revealed by high-density cDNA array hybridization Oncogene. 21 3253 3257 12082642 10.1038/sj.onc.1205431 1:CAS:528:DC%2BD38XktFGjs74%3D (Pubitemid 34548097)
17. CB Diep K Kleivi FR Ribeiro MR Teixeira OC Lindgjaerde RA Lothe 2006 The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes Genes Chromosomes Cancer. 45 31 41 16145679 10.1002/gcc.20261 1:CAS:528:DC%2BD2MXht1Kgu7%2FE (Pubitemid 46930859)
18. K Nakao KR Mehta J Fridlyand DH Moore AN Jain A Lafuente, et al. 2004 High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization Carcinogenesis. 25 1345 1357 15001537 10.1093/carcin/bgh134 1:CAS:528:DC%2BD2cXmtF2nsbg%3D (Pubitemid 39162701)
19. M Sheffer MD Bacolod O Zuk SF Giardina H Pincas F Barany, et al. 2009 Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer Proc Natl Acad Sci USA. 106 7131 7136 19359472 10.1073/pnas.0902232106 1:CAS:528:DC%2BD1MXlvVyisrc%3D
20. D Tsafrir M Bacolod Z Selvanayagam I Tsafrir J Shia Z Zeng, et al. 2006 Relationship of gene expression and chromosomal abnormalities in colorectal cancer Cancer Res. 66 2129 2137 16489013 10.1158/0008-5472.CAN-05-2569 1:CAS:528:DC%2BD28XhsFalsrw%3D
21. MD Bacolod GS Schemmann SF Giardina P Paty DA Notterman F Barany 2009 Emerging paradigms in cancer genetics: some important findings from high density SNP array studies Cancer Res. 69 723 727 19155292 10.1158/0008-5472.CAN-08-3543 1:CAS:528:DC%2BD1MXhtFOks7o%3D
22. CL Andersen C Wiuf M Kruhoffer M Korsgaard S Laurberg TF Orntoft 2007 Frequent occurrence of uniparental disomy in colorectal cancer Carcinogenesis. 28 38 48 16774939 10.1093/carcin/bgl086 1:CAS:528:DC%2BD28XhtlChtbvM (Pubitemid 44942625)
23. GY Locker S Hamilton J Harris JM Jessup N Kemeny JS Macdonald, et al. 2006 ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer J Clin Oncol. 24 5313 5327 17060676 10.1200/JCO.2006.08. 2644 1:CAS:528:DC%2BD28XhtlemurfN (Pubitemid 46631379)
24. Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol. 28:264-71.
25. Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart A. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J Clin Oncol. 28:256-63.
26. MG Mutch 2007 Molecular profiling and risk stratification of adenocarcinoma of the colon J Surg Oncol. 96 693 703 18081153 10.1002/jso.20915
27. T Andre C Boni M Navarro J Tabernero T Hickish C Topham, et al. 2009 Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial J Clin Oncol. 27 3109 3116 19451431 10.1200/JCO.2008.20.6771 1:CAS:528: DC%2BD1MXhtFWitbzF
28. C Bokemeyer I Bondarenko A Makhson JT Hartmann J Aparicio F de Braud, et al. 2009 Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer J Clin Oncol. 27 663 671 19114683 10.1200/JCO.2008.20.8397 1:CAS:528:DC%2BD1MXjsVCjsrk%3D
29. A Falcone S Ricci I Brunetti E Pfanner G Allegrini C Barbara, et al. 2007 Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest J Clin Oncol. 25 1670 1676 17470860 10.1200/JCO.2006.09.0928 1:CAS:528:DC%2BD2sXlvFyktb8%3D (Pubitemid 46797946)
30. A Barrier PY Boelle F Roser J Gregg C Tse D Brault, et al. 2006 Stage II colon cancer prognosis prediction by tumor gene expression profiling J Clin Oncol. 24 4685 4691 16966692 10.1200/JCO.2005.05.0229 1:CAS:528: DC%2BD28XhtFynsr3N (Pubitemid 46630932)
31. D Arango P Laiho A Kokko P Alhopuro H Sammalkorpi R Salovaara, et al. 2005 Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer Gastroenterology. 129 874 884 16143127 10.1053/j.gastro.2005.06.066 1:CAS:528:DC%2BD2MXhtV2isrvJ (Pubitemid 41242680)
32. Y Wang T Jatkoe Y Zhang MG Mutch D Talantov J Jiang, et al. 2004 Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer J Clin Oncol. 22 1564 1571 15051756 10.1200/JCO.2004.08.186 1:CAS:528:DC%2BD2cXpsVWmurw%3D (Pubitemid 41079793)
33. MJ O'Connell I Lavery G Yothers S Paik KM Clark-Langone M Lopatin, et al. 2010 Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin J Clin Oncol. 28 3937 3944 20679606 10.1200/JCO.2010.28.9538
34. R Gray J Barnwell C McConkey J Barnwell 2007 Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study Lancet. 370 2020 2029 18083404 10.1016/S0140-6736(07)61058-7 (Pubitemid 47069514)
35. Webber EM, Lin JS, Evelyn PW. Oncotype DX tumor gene expression profiling in stage II colon cancer. Application: prognostic, risk prediction. PLoS Curr. 2010;2.
36. S Popat R Hubner RS Houlston 2005 Systematic review of microsatellite instability and colorectal cancer prognosis J Clin Oncol. 23 609 618 15659508 10.1200/JCO.2005.01.086 1:CAS:528:DC%2BD2MXitVartLY%3D (Pubitemid 46224239)
37. C Guastadisegni M Colafranceschi L Ottini E Dogliotti 2010 Microsatellite instability as a marker of prognosis and response to therapy: A meta-analysis of colorectal cancer survival data Eur J Cancer. 46 2788 2798 20627535 10.1016/j.ejca.2010.05.009 1:CAS:528:DC%2BC3cXht1WhtrjO
38. CM Ribic DJ Sargent MJ Moore SN Thibodeau AJ French RM Goldberg, et al. 2003 Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med. 349 247 257 12867608 10.1056/NEJMoa022289 1:CAS:528:DC%2BD3sXlsVGjsbY%3D (Pubitemid 36859476)
39. DJ Sargent S Marsoni G Monges SN Thibodeau R Labianca SR Hamilton, et al. 2010 Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer J Clin Oncol. 28 3219 3226 20498393 10.1200/JCO.2009.27.1825 1:CAS:528:DC%2BC3cXhtVajurzE
40. ST Kim J Lee SH Park JO Park HY Lim WK Kang, et al. 2010 Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy Cancer Chemother Pharmacol. 66 659 667 20033812 10.1007/s00280-009-1206-3 1:CAS:528:DC%2BC3cXoslymtbc%3D
41. K Ng D Schrag 2010 Microsatellite instability and adjuvant fluorouracil chemotherapy: a mismatch? J Clin Oncol. 28 3207 3210 20498398 10.1200/JCO.2010.28.9314 1:CAS:528:DC%2BC3cXhtVajurzJ
42. MD Bacolod F Barany 2010 Gene dysregulations driven by somatic copy number aberrations-biological and clinical implications in colon tumors. A paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology J Mol Diagn. 12 552 561 20709793 10.2353/jmoldx.2010.100098 1:CAS:528: DC%2BC3cXht1eqsr7P
43. G Lanza M Matteuzzi R Gafa E Orvieto I Maestri A Santini, et al. 1998 Chromosome 18q allelic loss and prognosis in stage II and III colon cancer Int J Cancer. 79 390 395 9699532 10.1002/(SICI)1097-0215(19980821)79:4<390::AID- IJC14>3.0.CO;2-9 1:CAS:528:DyaK1cXltVems7o%3D (Pubitemid 28359738)
44. T Watanabe TT Wu PJ Catalano T Ueki R Satriano DG Haller, et al. 2001 Molecular predictors of survival after adjuvant chemotherapy for colon cancer N Engl J Med. 344 1196 1206 11309634 10.1056/NEJM200104193441603 1:CAS:528:DC%2BD3MXjsV2ms74%3D (Pubitemid 32319494)
45. AB Benson 3rd 2007 New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease Clin Cancer Res. 13 6913s 6920s 18006800 10.1158/1078-0432.CCR-07-1188 (Pubitemid 350206839)
46. G Tarafa A Villanueva L Farre J Rodriguez E Musulen G Reyes, et al. 2000 DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination Oncogene. 19 546 555 10698524 10.1038/sj.onc.1203353 1:CAS:528: DC%2BD3cXhsVyjurw%3D (Pubitemid 30099368)
47. ER Fearon KR Cho JM Nigro SE Kern JW Simons JM Ruppert, et al. 1990 Identification of a chromosome 18q gene that is altered in colorectal cancers Science. 247 49 56 2294591 10.1126/science.2294591 1:CAS:528: DyaK3cXptlSnuw%3D%3D
48. YK Shin BC Yoo HJ Chang E Jeon SH Hong MS Jung, et al. 2005 Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance Cancer Res. 65 3162 3170 15833846 1:CAS:528:DC%2BD2MXjt1ykt7Y%3D (Pubitemid 40524597)
49. XP Liu S Kawauchi A Oga T Sato K Ikemoto E Ikeda, et al. 2007 Chromosomal aberrations detected by comparative genomic hybridization predict outcome in patients with colorectal carcinoma Oncol Rep. 17 261 267 17143507 1:CAS:528:DC%2BD2sXhtFagur4%3D
50. F Al-Mulla AI Behbehani MS Bitar G Varadharaj JJ Going 2006 Genetic profiling of stage I and II colorectal cancer may predict metastatic relapse Mod Pathol. 19 648 658 16528379 10.1038/modpathol.3800564 1:CAS:528: DC%2BD28Xjs1agtbo%3D
51. C Zuern J Heimrich R Kaufmann KK Richter U Settmacher C Wanner, et al. 2010 Down-regulation of MTUS1 in human colon tumors Oncol Rep. 23 183 189 19956880 1:CAS:528:DC%2BC3cXoslGgtQ%3D%3D
52. S Rodrigues-Ferreira A Di Tommaso A Dimitrov S Cazaubon N Gruel H Colasson, et al. 2009 8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis PLoS One. 4 e7239 19794912 10.1371/journal.pone.0007239
53. S Seibold C Rudroff M Weber J Galle C Wanner M Marx 2003 Identification of a new tumor suppressor gene located at chromosome 8p21.3-22 FASEB J 17 1180 1182 12692079 1:CAS:528:DC%2BD3sXktl2js7c%3D
54. J Westermarck WC Hahn 2008 Multiple pathways regulated by the tumor suppressor PP2A in transformation Trends Mol Med. 14 152 160 18329957 10.1016/j.molmed.2008.02.001 1:CAS:528:DC%2BD1cXktlCktLo%3D
55. J Tol CJ Punt 2010 Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review Clin Ther. 32 437 453 20399983 10.1016/j.clinthera. 2010.03.012 1:CAS:528:DC%2BC3cXosVWqu7k%3D
56. H Modjtahedi S Essapen 2009 Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities Anticancer Drugs. 20 851 855 19826350 10.1097/CAD.0b013e3283330590 1:CAS:528:DC%2BD1MXht1GitrvM
57. CJ Allegra JM Jessup MR Somerfield SR Hamilton EH Hammond DF Hayes, et al. 2009 American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy J Clin Oncol. 27 2091 2096 19188670 10.1200/JCO.2009.21.9170
58. P Laurent-Puig A Cayre G Manceau E Buc JB Bachet T Lecomte, et al. 2009 Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer J Clin Oncol. 27 5924 5930 19884556 10.1200/JCO.2008.21.6796 1:CAS:528:DC%2BC3cXhtVWis7c%3D
59. MJ Waldner MF Neurath 2010 The molecular therapy of colorectal cancer Mol Aspects Med. 31 171 178 20171980 10.1016/j.mam.2010.02.005 1:CAS:528: DC%2BC3cXksFGqurY%3D
60. A Tenesa MG Dunlop 2009 New insights into the aetiology of colorectal cancer from genome-wide association studies Nat Rev Genet. 10 353 358 19434079 10.1038/nrg2574 1:CAS:528:DC%2BD1MXmtVKrsLs%3D
61. R Venkatachalam MJ Ligtenberg N Hoogerbrugge A Geurts van Kessel RP Kuiper 2008 Predisposition to colorectal cancer: exploiting copy number variation to identify novel predisposing genes and mechanisms Cytogenet Genome Res. 123 188 194 19287155 10.1159/000184708 1:STN:280:DC%2BD1M3gvFeisQ%3D%3D
62. MD Bacolod GS Schemmann S Wang R Shattock SF Giardina Z Zeng, et al. 2008 The signatures of autozygosity among patients with colorectal cancer Cancer Res. 68 2610 2621 18375840 10.1158/0008-5472.CAN-07-5250 1:CAS:528: DC%2BD1cXks1GitL0%3D (Pubitemid 351559606)